Long-Term Safety Study of Buprenorphine (CAM2038) in Adult Outpatients With Opioid Use Disorder

PHASE3CompletedINTERVENTIONAL
Enrollment

228

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

May 31, 2017

Study Completion Date

May 31, 2017

Conditions
Opioid Use Disorder
Interventions
DRUG

CAM2038 q1w or q4w exposure to SL BPN/NX

DRUG

CAM2038 q1w or q4w new to BPN treatment

Trial Locations (32)

103

Taipei City Hospital, Taipei

717

Jinan Psychiatric Center, Ministry of Health and Welfa, Tainan City

1033

Clinexpert Kft, Budapest

1165

XVI. Kerület Kertvárosi Egészségügyi Szolgálata, Addiktológia, Budapest

2050

Royal Prince Alfred Hospital, Sydney

5000

Behandlingscenter Odense, Odense

5070

Drug & Alcohol Services SA Drug and Alcohol Services, Norwood

8000

Center for Misbrugsbehandling, Aarhus

10019

STARS/Columbia University, New York

19428

Frost Medical Group, LLC, Conshohocken

32256

Dr Vijapura and Associates, Jacksonville

32751

TRY Research, Maitland

34117

Studikum - Zentrum fur Klinische Studien im Praxiszentrum Friedrichsplatz, Kassel

35215

Parkway Medical Center, Birmingham

35565

Haleyville Clinical Research LLC, Haleyville

35570

Boyett Health Services Inc, Hamilton

40447

China Medical University Hospita, Taichung

68159

Klinik fur Abhangiges Verhalten und Suchtmedizin Zentralinstitut, Mannheim

70197

Praxisgemeinschaft, Stuttgart

72189

Centrallasarettet Vasteras, Västerås

74076

Gemeinschaftspraxis Schnaitmann/Schaffert Salzstrasse, Heilbronn

93051

Psychosoziale Begleitung - Praxis Boniakowski, Regensburg

02720

Stanley Street Treatment and Resources Inc, Fall River

07823

Wellness and Research Center, Belvidere

08009

Comprehensive Clinical Research, Berlin

NSW 2300

Newcastle Community Health Services, Newcastle

NSW 2010

South Eastern Sydney Local Health District (SESLHD), Sydney

118 67

Metadonsektionen, Stockholm

BS16 2EW

Blackberry Centre Blackberry Hill Hospital, Fishponds

NR6 5BE

Hellesdon Hospital The Weavers Centre, Hellesdon

DD1 9SY

NHS Tayside, Dundee

SW9 8DG

Lambeth Drug and Alcohol Service Lorraine Hewitt House, London

Sponsors
All Listed Sponsors
lead

Braeburn Pharmaceuticals

INDUSTRY